ID   MYH7_RAT                Reviewed;        1935 AA.
AC   P02564;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 2.
DT   24-JUL-2024, entry version 185.
DE   RecName: Full=Myosin-7;
DE   AltName: Full=Myosin heavy chain 7;
DE   AltName: Full=Myosin heavy chain slow isoform;
DE            Short=MyHC-slow;
DE   AltName: Full=Myosin heavy chain, cardiac muscle beta isoform;
DE            Short=MyHC-beta;
GN   Name=Myh7;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RX   PubMed=2798112; DOI=10.1093/nar/17.18.7529;
RA   Kraft R., Bravo-Zehnder M., Taylor D., Leinwand L.A.;
RT   "Complete nucleotide sequence of full length cDNA for rat beta cardiac
RT   myosin heavy chain.";
RL   Nucleic Acids Res. 17:7529-7530(1989).
RN   [2]
RP   DISCUSSION OF SEQUENCE.
RX   PubMed=2614840; DOI=10.1016/0022-2836(89)90141-1;
RA   McNally E.M., Kraft R., Bravo-Zehnder M., Taylor D., Leinwand L.A.;
RT   "Full-length rat alpha and beta cardiac myosin heavy chain sequences.
RT   Comparisons suggest a molecular basis for functional differences.";
RL   J. Mol. Biol. 210:665-671(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1524-1935.
RX   PubMed=7045682; DOI=10.1038/297659a0;
RA   Mahdavi V., Periasamy M., Nadal-Ginard B.;
RT   "Molecular characterization of two myosin heavy chain genes expressed in
RT   the adult heart.";
RL   Nature 297:659-664(1982).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1871-1935.
RC   STRAIN=Wistar; TISSUE=Heart;
RX   PubMed=6241892; DOI=10.1093/eurheartj/5.suppl_f.181;
RA   Mahdavi V., Lompre A.M., Chambers A.P., Nadal-Ginard B.;
RT   "Cardiac myosin heavy chain isozymic transitions during development and
RT   under pathological conditions are regulated at the level of mRNA
RT   availability.";
RL   Eur. Heart J. 5:181-191(1984).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1510, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   DOMAIN, FUNCTION, MUTAGENESIS OF THR-1188; GLU-1385; GLU-1582 AND GLY-1807,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=26150528; DOI=10.1073/pnas.1505813112;
RA   Taylor K.C., Buvoli M., Korkmaz E.N., Buvoli A., Zheng Y., Heinze N.T.,
RA   Cui Q., Leinwand L.A., Rayment I.;
RT   "Skip residues modulate the structural properties of the myosin rod and
RT   guide thick filament assembly.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:E3806-E3815(2015).
CC   -!- FUNCTION: Myosins are actin-based motor molecules with ATPase activity
CC       essential for muscle contraction. Forms regular bipolar thick filaments
CC       that, together with actin thin filaments, constitute the fundamental
CC       contractile unit of skeletal and cardiac muscle.
CC       {ECO:0000305|PubMed:26150528}.
CC   -!- SUBUNIT: Muscle myosin is a hexameric protein that consists of 2 heavy
CC       chain subunits (MHC), 2 alkali light chain subunits (MLC) and 2
CC       regulatory light chain subunits (MLC-2). Interacts with ECPAS.
CC       Interacts (via C-terminus) with LRRC39. {ECO:0000250|UniProtKB:P12883}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, myofibril
CC       {ECO:0000269|PubMed:26150528}. Cytoplasm, myofibril, sarcomere
CC       {ECO:0000269|PubMed:26150528}. Note=Thick filaments of the myofibrils.
CC       {ECO:0000269|PubMed:26150528}.
CC   -!- DOMAIN: The rodlike tail sequence is highly repetitive, showing cycles
CC       of a 28-residue repeat pattern composed of 4 heptapeptides,
CC       characteristic for alpha-helical coiled coils. Four skip residues
CC       (Skip1: Thr-1188, Skip2: Glu-1385, Skip3: Glu-1582 and Skip4: Gly-1807)
CC       introduce discontinuities in the coiled-coil heptad repeats. The first
CC       three skip residues are structurally comparable and induce a unique
CC       local relaxation of the coiled-coil superhelical pitch and the fourth
CC       skip residue lies within a highly flexible molecular hinge that is
CC       necessary for myosin incorporation in the bare zone of sarcomeres
CC       (PubMed:26150528). {ECO:0000269|PubMed:26150528}.
CC   -!- DOMAIN: Limited proteolysis of myosin heavy chain produces 1 light
CC       meromyosin (LMM) and 1 heavy meromyosin (HMM). HMM can be further
CC       cleaved into 2 globular subfragments (S1) and 1 rod-shaped subfragment
CC       (S2). {ECO:0000305}.
CC   -!- MISCELLANEOUS: The cardiac alpha isoform is a 'fast' ATPase myosin,
CC       while the beta isoform is a 'slow' ATPase.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- CAUTION: Represents a conventional myosin. This protein should not be
CC       confused with the unconventional myosin-7 (MYO7). {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X15939; CAA34065.1; -; mRNA.
DR   EMBL; J00752; AAA41654.1; -; mRNA.
DR   EMBL; M32698; AAA41659.1; -; mRNA.
DR   PIR; S06006; S06006.
DR   RefSeq; NP_058936.1; NM_017240.2.
DR   AlphaFoldDB; P02564; -.
DR   SMR; P02564; -.
DR   BioGRID; 248191; 3.
DR   IntAct; P02564; 1.
DR   STRING; 10116.ENSRNOP00000024186; -.
DR   GlyGen; P02564; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P02564; -.
DR   PhosphoSitePlus; P02564; -.
DR   jPOST; P02564; -.
DR   PaxDb; 10116-ENSRNOP00000024186; -.
DR   ABCD; P02564; 1 sequenced antibody.
DR   GeneID; 29557; -.
DR   KEGG; rno:29557; -.
DR   UCSC; RGD:62030; rat.
DR   AGR; RGD:62030; -.
DR   CTD; 4625; -.
DR   RGD; 62030; Myh7.
DR   eggNOG; KOG0161; Eukaryota.
DR   InParanoid; P02564; -.
DR   OrthoDB; 2877572at2759; -.
DR   PhylomeDB; P02564; -.
DR   PRO; PR:P02564; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005859; C:muscle myosin complex; IDA:RGD.
DR   GO; GO:0030016; C:myofibril; IDA:UniProtKB.
DR   GO; GO:0016459; C:myosin complex; ISO:RGD.
DR   GO; GO:0032982; C:myosin filament; IDA:UniProtKB.
DR   GO; GO:0016460; C:myosin II complex; IBA:GO_Central.
DR   GO; GO:0030017; C:sarcomere; IDA:UniProtKB.
DR   GO; GO:0001725; C:stress fiber; ISO:RGD.
DR   GO; GO:0030018; C:Z disc; ISO:RGD.
DR   GO; GO:0051015; F:actin filament binding; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IMP:RGD.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IMP:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0000146; F:microfilament motor activity; IMP:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0007512; P:adult heart development; ISO:RGD.
DR   GO; GO:0046034; P:ATP metabolic process; ISO:RGD.
DR   GO; GO:0060048; P:cardiac muscle contraction; ISO:RGD.
DR   GO; GO:0014898; P:cardiac muscle hypertrophy in response to stress; ISO:RGD.
DR   GO; GO:1905243; P:cellular response to 3,3',5-triiodo-L-thyronine; IEP:RGD.
DR   GO; GO:1904385; P:cellular response to angiotensin; IEP:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0006936; P:muscle contraction; IMP:RGD.
DR   GO; GO:0030049; P:muscle filament sliding; ISO:RGD.
DR   GO; GO:0002027; P:regulation of heart rate; ISO:RGD.
DR   GO; GO:0031449; P:regulation of slow-twitch skeletal muscle fiber contraction; ISO:RGD.
DR   GO; GO:0002026; P:regulation of the force of heart contraction; ISO:RGD.
DR   GO; GO:0014728; P:regulation of the force of skeletal muscle contraction; ISO:RGD.
DR   GO; GO:0045214; P:sarcomere organization; IBA:GO_Central.
DR   GO; GO:0003009; P:skeletal muscle contraction; ISO:RGD.
DR   GO; GO:0006941; P:striated muscle contraction; ISO:RGD.
DR   GO; GO:0014883; P:transition between fast and slow fiber; ISO:RGD.
DR   GO; GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISO:RGD.
DR   CDD; cd01377; MYSc_class_II; 1.
DR   Gene3D; 1.10.10.820; -; 1.
DR   Gene3D; 1.20.5.340; -; 5.
DR   Gene3D; 1.20.5.370; -; 4.
DR   Gene3D; 1.20.5.4820; -; 1.
DR   Gene3D; 1.20.58.530; -; 1.
DR   Gene3D; 6.10.250.2420; -; 1.
DR   Gene3D; 3.40.850.10; Kinesin motor domain; 1.
DR   Gene3D; 2.30.30.360; Myosin S1 fragment, N-terminal; 1.
DR   Gene3D; 1.20.120.720; Myosin VI head, motor domain, U50 subdomain; 1.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR014751; XRCC4-like_C.
DR   PANTHER; PTHR45615; MYOSIN HEAVY CHAIN, NON-MUSCLE; 1.
DR   PANTHER; PTHR45615:SF1; MYOSIN-7; 1.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF02736; Myosin_N; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF90257; Myosin rod fragments; 4.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF57997; Tropomyosin; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   1: Evidence at protein level;
KW   Actin-binding; ATP-binding; Calmodulin-binding; Coiled coil; Cytoplasm;
KW   Methylation; Motor protein; Muscle protein; Myosin; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Thick filament.
FT   CHAIN           1..1935
FT                   /note="Myosin-7"
FT                   /id="PRO_0000123411"
FT   DOMAIN          32..81
FT                   /note="Myosin N-terminal SH3-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01190"
FT   DOMAIN          85..778
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   DOMAIN          781..810
FT                   /note="IQ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   REGION          655..677
FT                   /note="Actin-binding"
FT   REGION          757..771
FT                   /note="Actin-binding"
FT   REGION          1915..1935
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          840..1935
FT                   /evidence="ECO:0000255"
FT   BINDING         178..185
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   MOD_RES         129
FT                   /note="N6,N6,N6-trimethyllysine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         378
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P02563"
FT   MOD_RES         1137
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P02563"
FT   MOD_RES         1269
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q02566"
FT   MOD_RES         1282
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P02563"
FT   MOD_RES         1308
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P02563"
FT   MOD_RES         1309
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P02563"
FT   MOD_RES         1510
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1513
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P02563"
FT   MUTAGEN         1188
FT                   /note="Missing: No effect on myosin incorporation into
FT                   sarcomeres."
FT                   /evidence="ECO:0000269|PubMed:26150528"
FT   MUTAGEN         1385
FT                   /note="Missing: No effect on myosin incorporation into
FT                   sarcomeres."
FT                   /evidence="ECO:0000269|PubMed:26150528"
FT   MUTAGEN         1582
FT                   /note="Missing: No effect on myosin incorporation into
FT                   sarcomeres. Causes myosin cytoplasmic aggregates that show
FT                   a sponge-like structure."
FT                   /evidence="ECO:0000269|PubMed:26150528"
FT   MUTAGEN         1807
FT                   /note="Missing: No effect on myosin incorporation into
FT                   sarcomeres. Disrupts location on the sarcomere bare zone."
FT                   /evidence="ECO:0000269|PubMed:26150528"
FT   CONFLICT        1529..1531
FT                   /note="IRK -> VRR (in Ref. 3; AAA41654)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1731
FT                   /note="D -> H (in Ref. 3; AAA41654)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1784
FT                   /note="N -> K (in Ref. 3; AAA41654)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1851
FT                   /note="T -> N (in Ref. 3; AAA41654)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1858
FT                   /note="R -> K (in Ref. 3; AAA41654)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1935 AA;  223083 MW;  C8376C324A7BD82B CRC64;
     MADREMAAFG AGAPFLRKSE KERLEAQTRP FDLKKDVFVP DDKEEFVKAK IVSREGGKVT
     AETENGKTVT VKEDQVMQQN PPKFDKIEDM AMLTFLHEPA VLYNLKERYA SWMIYTYSGL
     FCVTVNPYKW LPVYNAQVVA AYRGKKRSEA PPHIFSISDN AYQYMLTDRE NQSILITGES
     GAGKTVNTKR VIQYFAVIAA IGDRSKKDQT PGKGTLEDQI IQANPALEAF GNAKTVRNDN
     SSRFGKFIRI HFGATGKLAS ADIETYLLEK SRVIFQLKAE RDYHIFYQIL SNKKPELLDM
     LLITNNPYDY AFFSQGETTV ASIDDSEEHM ATDSAFDVLG FTPEEKNSIY KLTGAIMHFG
     NMKFKQKQRE EQAEPDGTEE ADKSAYLMGL NSADLLKGLC HPRVKVGNEY VTKGQNVQQV
     AYAIGALAKS VYEKMFNWMV TRINATLETK QPRQYFIGVL DIAGFEIFDF NSFEQLCINF
     TNEKLQQFFN HHMFVLEQEE YKKEGIEWTF IDFGMDLQAC IDLIEKPMGI MSILEEECMF
     PKATDMTFKA KLYDNHLGKS NNFQKPRNIK GKQEAHFSLI HYAGTVDYNI LGWLQKNKDP
     LNETVVGLYQ KSSLKLLSNL FANYAGADAP VDKGKGKAKK GSSFQTVSAL HRENLNKLMT
     NLRSTHPHFV RCIIPNETKS PGVMDNPLVM HQLRCNGVLE GIRICRKGFP NRILYGDFRQ
     RYRILNPAAI PEGQFIDSRK GAEKLLGSLD IDHNQYKFGH TKVFFKAGLL GLLEEMRDER
     LSRIITRIQA QSRGVLSRME FKKLLERRDS LLIIQWNIRA FMGVKNWPWM KLYFKIKPLL
     KSAETEKEMA NMKEEFGRVK DALEKSEARR KELEEKMVSL LQEKNDLQLQ VQAEQDNLAD
     AEERCDQLIK NKIQLEAKVK EMTERLEDEE EMNAELTAKK RKLEDECSEL KRDIDDLELT
     LAKVEKEKHA TENKVKNLTE EMAGLDEIIV KLTKEKKALQ EAHQQALDDL QAEEDKVNTL
     TKAKVKLEQQ VDDLEGSLDQ DKKVRMDLER AKRKLEGDLK LTQESIMDLE NDKQQLDERL
     KKKDFELNAL NARIEDEQAL GSQLQKKLKE LQARIEELEE ELEAERTARA KVEKLRSDLS
     RELEEISERL EEAGGATSVQ IEMNKKREAE FQKMRRDLEE ATLQHEATAA ALRKKHADSV
     AELGEQIDNL QRVKQKLEKE KSEFKLELDD VTSNMEQIIK AKANLEKMCR TLEDQMNEHR
     SKAEETQRSV NDLTRQRAKL QTENGELSRQ LDEKEALISQ LTRGKLTYTQ QLEDLKRQLE
     EEVKAKNALA HALQSARHDC DLLREQYEEE TEAKAELQRV LSKANSEVAQ WRTKYETDAI
     QRTEELEEAK KKLAQRLQDA EEAVEAVNAK CSSLEKTKHR LQNEIEDLMV DVERSNAAAA
     ALDKKQRNFD KILVEWKQKY EESQSELESS QKEARSLSTE LFKLKNAYEE SLEHLETFKR
     ENKNLQEEIS DLTEQLGSTG KSIHELEKIR KQLEAEKLEL QSALEEAEAS LEHEEGKILR
     AQLEFNQIKA EIERKLAEKD EEMEQAKRNH LRVVDSLQTS LDAETRSRNE ALRVKKKMEG
     DLNEMEIQLS HANRMAAEAQ KQVKSLQSLL KDTQIQLDDA VRANDDLKEN IAIVERRNNL
     LQAELEELRA VVEQTERSRK LAEQELIETS ERVQLLHSQN TSLINQKKKM DADLSQLQTE
     VEEAVQECRN AEEKAKKAIT DAAMMAEELK KEQDTSAHLE RMKNNMEQTI KDLQHRLDEA
     EQIALKGGKK QLQKLEARVR ELENELEAEQ KRNAESVKGM RKSERRIKEL TYQTEEDRKN
     LLRLQDLVDK LQLKVKAYKR QAEEAEEQAN TNLSKFRKVQ HELDEAEERA DIAESQVNKL
     RAKSRDIGAK GLNEE
//
